top of page


Martin Schutten

Martin Schutten picture 2(1) (1)_edited_edited.jpg

Martin's experience in virology dates back to 1990 when he started doing HIV-1/2 basic research. In order to broaden his knowledge in the field of virology he changed positions in 1998 and started working in the field of virus diagnostics.
In 2009 he became Head of the unit Clinical Virology and became responsible for finance, HRM and quality of the virus diagnostic portfolio.

In January 2015 he started working full time as the Director Clinical Services at Viroclinics Biosciences BV, mainly responsible for implementation and maintenance of culture, serological and molecular diagnostic assays, global clinical trial operations business development and client contacts. At the same time he also took up a part time job as assessor ISO15189 for the Dutch Board for Accreditation.

By working more than 17 years in both academic and commercial virus diagnostic laboratories he has built up experience in managing an ISO15189 accredited laboratory with more than 40 co-workers and developing and implementation of diagnostic methods and implementing logistic operations for patient management and clinical trials. During that time he also weekly attended the infectious disease specialists meetings and thus aquired in depth knowledge on treatment of patients infected with a range of different viral diseases.

Martin has been on missions to the Middle East (Syria/Lebanon/Egypt), West Africa (Cape Verde Isles/Gambia/Guinee Conakry), Brazil and Indonesia to assist WHO and local governments in evaluating country preparedness for virus outbreaks and was amongst others involved in the global outbreak response for SARS-CoV-1; influenza H1N1pdm09 and Ebola.

As consultant Martin built up extensive experience with pre-clinical development, human challenge studies and clinical trial management for antivirals and vaccines.

Next to his role as Chief Scientific Officer at CHIMunomics, Martin is also the (co-)founder of Clinical Virology And Diagnostics (his own consultancy company), CHIMagents (sold to Open Orphan LtD as of July 2021)m, Artemis BioServices (CRO specialized in virus diagnostics) and IQ-IDM (Biotech developing new antivirals).

bottom of page